Skip to main content

COVID-19 booster vaccine

Like some other vaccines, levels of protection may begin to wane over time. This booster dose will help extend the protection you gained from your first two doses and give you longer term protection. The booster will help to reduce the risk of you needing admission to hospital due to COVID-19 infection this winter.

The booster can be offered at least three months after your last dose.

If you are eligible for a booster and it has been three months since your second or third dose, please attend a drop-in clinic (opens in new tab) as soon as possible.

If you are unable to attend a drop-in clinic, please arrange an appointment by contacting the health board directly on 0300 303 8322 or

Who is eligible for a COVID-19 booster vaccine?

  • Everyone aged 16 and over 
  • people aged 12 years and over with a severely weakened immune system who have had a third primary dose (opens in new tab) 
  • children and young people aged 12 to 15 years who are at increased risk from coronavirus due to underlying health conditions 
  • children and young people aged 12 to 15 years who live with someone with a weakened immune system

Spring booster

Appointments for the COVID-19 spring booster vaccine have started for those who are eligible at mass vaccination centres and at most GP practices.

COVID-19 is more serious in older people and those with a weakened immune system. For this reason, people aged 75 years and over, those in care homes and those aged 12 years and over with a weakened immune system (as defined in table 3 and 4 of the Green Book's chapter 14a (opens in new tab)) are being offered a spring booster.

The spring booster will be offered up until the end of June and is advised to be given around six months (and not before three months) after the last dose of vaccine was received to get the best protection.

The health board and participating GP practices are in the process of contacting people eligible for a spring booster of the COVID-19 vaccine. Appointments are being scheduled in line with the latest JCVI advice and in accordance with age and clinical vulnerability.